Home 2017-09-13T23:47:18+00:00

The new science of accelerating innovation

Omics + big data + biomarker-guided drug development. It’s a new reality, bringing unprecedented abilities to interrogate and translate biological information—and unprecedented opportunities for life sciences companies to achieve their goals faster and more cost-effectively. This fundamental shift requires a new approach to drug development. Precision for Medicine is leading the way.

Explore our services
« Back

Precision for Medicine can help you find and extract the long-term value of innovative drugs

We develop your assays and manage global logistics, speeding to actionable answers. We use biomarkers to stratify patients, incomparably improving your R&D efficiency and success. We manage every aspect of your clinical trials from sites to biomarkers to diagnostics, all under a single roof. In short: we dramatically accelerate your pathway from proof of concept to drug approval.

News & Insights
  • Precision's Messerschmidt Talks Immunotherapy with ASCO Post

  • Briefing: Best Practices for the Expedited Start-Up of Oncology Trials

    Precision subject matter expert, Tandy Tipps, highlights how oncology sites can...

Thought Leadership
  • Precision's David Parker Discusses CDx Development Relationships with Clinical Omics

  • Perspective: Convergence of CLIA and FDA Requirements: A Rationale Shift in the Regulatory Paradigm

    The laboratory developed test (LDT) has proven to be a flexible, quick, lower-in...

  • 6 Critical Factors for Achieving Approval of Oncology Drugs

    In this high-stakes, high-velocity environment of oncology drug development and...